Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04)[...]
Lineage Cell Therapeutics Inc.
Quarterly report which provides a continuing view of a company's[...]
11/06/2024 | Press release | Distributed by Public on 11/06/2024 03:39
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact